Allergan Breaks Ground on $200 Million Waco Facility Expansion

By Staff
Wednesday, April 27, 2016 12:18 AM WACO, Texas—Allergan plc (NYSE: AGN), broke ground Monday on a $200 million expansion of its Waco, Texas facility.

Allergan Acquires Dermatology Company Topokine Therapeutics

By Staff
Monday, April 25, 2016 12:23 AM DUBLIN and BOSTON—Allergan plc has acquired Topokine Therapeutics, a privately held, clinical-stage biotechnology company focused on developing topical medicines for fat reduction.

Advancing Diversity Leadership Adds New Members to its Board and Membership Committee

By Staff
Monday, March 21, 2016 12:18 AM KANSAS CITY, Mo.— OWL, Advancing Diversity Leadership, has added Michael Onuscheck and Erin Schallhorn to its board of directors.

Victor T. Curtin, MD, Professor at Bascom Palmer Eye Institute, Passes Away at 91

By Staff
Wednesday, March 16, 2016 12:15 AM MIAMI—Professor emeritus of ophthalmology at Bascom Palmer Eye Institute, Victor T. Curtin, MD, passed away here on March 9 at age 91.

FDA Approves Marketing of Triggerfish, a Sensor-Equipped CL That Measures Intraocular Pressure

By Staff
Wednesday, March 9, 2016 12:27 AM SILVER SPRING, Md.—The U.S. Food and Drug Administration is allowing marketing of a one-time use contact lens that may help practitioners identify the best time of day to measure a patient’s intraocular pressure (IOP).

Wills Eye Hospital Names Dr. Leslie Hyman Vice Chair for Research

By Staff
Monday, March 7, 2016 12:18 AM Philadelphia—Wills Eye Hospital has appointed Dr. Leslie G. Hyman, an internationally recognized leader in the field of vision research and public health, to spearhead the expansion of the Hospital’s research program.

Wade Delk Joins Staff of International Eyecare Organization

By Staff
Monday, February 29, 2016 12:18 AM ST. PAUL, Minn.—The Joint Commission on Allied Health Personnel in Ophthalmology (JCAHPO) has appointed Wade Delk as the executive director of the Center for Organizational Management (CFOM), an association management company (AMC), and as JCAHPO’s director of public affairs.

Opternative Raises $6.0 Million in New Round of Venture Funding

By Staff
Monday, February 22, 2016 12:22 AM CHICAGO—Opternative has raised $6.0 million in Series A venture funding which it will use to expand its online eye exam to more states, reach a broader age demographic and conduct research and development.

Johnson & Johnson 4Q Sales Drop 2.4 Percent, But U.S. Vision Care Sales Grow

By Staff
Wednesday, January 27, 2016 12:23 AM NEW BRUNSWICK, N.J.—Johnson & Johnson (NYSE: JNJ) announced sales of $17.8 billion for the fourth quarter of 2015, a decrease of 2.4 percent as compared to the fourth quarter of 2014.

William L. Rich III, MD, Begins Term as American Academy of Ophthalmology President

By Staff
Friday, January 8, 2016 12:21 AM SAN FRANCISCO—On Jan. 1, 2016, William L. Rich III, MD, FACS began his term as the 119th president of the American Academy of Ophthalmology.

Alphaeon Announces Plan to Acquire Integrity Digital Solutions

By Staff
Monday, November 16, 2015 12:24 AM IRVINE, Calif.—Alphaeon Corp., a lifestyle health care company, announced Friday its plan to acquire Integrity Digital Solutions, a developer of EMR software for ophthalmologists, for an undisclosed sum.

Top Exec Tells How Century-Old Company Remains Vital

By Andrew Karp
Monday, November 16, 2015 12:00 AM Walman doesn’t look a day over 100. In fact, the Minneapolis-based company, which is celebrating its centennial this year, doesn’t look or behave at all like a senior citizen. Although it is the largest independent ophthalmic company in the U.S., and one of the most diversified, Walman is agile and, when necessary, assertive.

InSite Vision and Sun Pharma Enter Into Merger Agreement

By Staff
Thursday, September 17, 2015 12:27 AM

ALAMEDA, Calif.—InSite Vision Inc. (OTCBB: INSV) announced yesterday that InSite and a subsidiary of Sun Pharmaceutical Industries Ltd. (Sun Pharma) have entered into a merger agreement under which an indirect wholly owned subsidiary of Sun Pharma will acquire InSite in an all-cash transaction for $0.35 per share, or approximately $48 million in aggregate equity value, on a fully diluted basis. The transaction has been approved by the boards of directors of both InSite and the Sun Pharma subsidiary, and will be completed by means of a tender offer.

VisionCare Ophthalmic Technologies Expands Executive Team

By Staff
Friday, September 11, 2015 12:18 AM SARATOGA, Calif.—VisionCare Ophthalmic Technologies, the developer, manufacturer and marketer of the Implantable Miniature Telescope, has named Blake Michaels as vice president, sales and current executive, Chet Kumar, as vice president, corporate development and innovation.

Allergan to Acquire Glaucoma Treatment Company AqueSys

By Staff
Friday, September 4, 2015 12:23 AM DUBLIN and ALISO VIEJO, Calif.—Allergan (NYSE: AGN), a leading global pharmaceutical company, and AqueSys, Inc. a private clinical stage medical device company focused on developing ocular implants that reduce intraocular pressure associated with glaucoma, announced yesterday that they have entered into an agreement under which Allergan will acquire AqueSys in an all-cash transaction.
Loading...